A detailed history of Neuberger Berman Group LLC transactions in Insmed Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 113,748 shares of INSM stock, worth $8.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
113,748
Previous 170,917 33.45%
Holding current value
$8.29 Million
Previous $4.64 Million 64.39%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$22.0 - $69.71 $1.26 Million - $3.99 Million
-57,169 Reduced 33.45%
113,748 $7.62 Million
Q1 2024

May 13, 2024

BUY
$25.72 - $29.94 $4.4 Million - $5.12 Million
170,917 New
170,917 $4.64 Million
Q4 2023

Feb 09, 2024

BUY
$23.42 - $31.74 $1.39 Million - $1.89 Million
59,424 Added 54.27%
168,928 $5.24 Million
Q3 2023

Nov 14, 2023

SELL
$19.86 - $26.93 $2.91 Million - $3.95 Million
-146,706 Reduced 57.26%
109,504 $2.76 Million
Q2 2023

Aug 11, 2023

BUY
$16.44 - $21.1 $1.77 Million - $2.27 Million
107,402 Added 72.17%
256,210 $5.41 Million
Q1 2023

May 12, 2023

BUY
$16.26 - $21.73 $182,843 - $244,353
11,245 Added 8.17%
148,808 $2.54 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $852,463 - $1.16 Million
50,204 Added 57.47%
137,563 $2.75 Million
Q3 2022

Nov 15, 2022

SELL
$20.88 - $28.21 $6,013 - $8,124
-288 Reduced 0.33%
87,359 $1.88 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $620,443 - $934,481
36,347 Added 70.85%
87,647 $1.73 Million
Q1 2022

May 13, 2022

BUY
$20.42 - $28.13 $104,407 - $143,828
5,113 Added 11.07%
51,300 $1.15 Million
Q4 2021

Feb 11, 2022

BUY
$25.89 - $33.45 $776 - $1,003
30 Added 0.06%
46,187 $1.25 Million
Q3 2021

Nov 12, 2021

SELL
$22.46 - $29.47 $1.68 Million - $2.21 Million
-75,000 Reduced 61.9%
46,157 $1.27 Million
Q2 2021

Aug 13, 2021

BUY
$24.17 - $36.01 $2.93 Million - $4.36 Million
121,157 New
121,157 $3.44 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.88B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.